TY - JOUR T1 - First report of a very rare complication in a case of nonsmall cell lung carcinoma JF - Breathe JO - Breathe DO - 10.1183/20734735.0107-2021 VL - 17 IS - 4 SP - 210107 AU - Inês Moreira AU - Ana Sofia Vilariça AU - Paula Alves Y1 - 2021/12/01 UR - http://breathe.ersjournals.com/content/17/4/210107.abstract N2 - While immune checkpoint inhibitors like pembrolizumab are promising agents for nonsmall cell lung carcinoma treatment, increased use is leading to increased immune-related adverse events, including endocrinopathies such as adrenal insufficiency. https://bit.ly/3iMfhUk ER -